About Index Trending news
Analyze
Pricing
NovImmune

NovImmune

NovImmune

NovImmmune develops therapeutic monoclonal antibodies to treat patients suffering from immune-related disorders.

Elsewhere

Alexa global traffic share

Latest funding Show all
Venture capital (Series D)
$22,413,980
BZ Bank
Venture capital (Series C)
$54,800,000
Employees

Team size

50+
Locations
HQ
Headquarters

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when NovImmune makes some noise.